Antonio Barreiro
Amer, LO 17170, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial.
Journal: Vaccine
Published: April 23, 2024
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Journal: International journal of molecular sciences
Published: April 14, 2023
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.
Journal: Vaccine
Published: January 09, 2023
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates.
Journal: iScience
Published: December 13, 2022
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.
Journal: The Lancet regional health. Europe
Published: October 19, 2022
Use of chemostat cultures mimicking different phases of wine fermentations as a tool for quantitative physiological analysis.
Journal: Microbial cell factories
Published: December 13, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026